Sales & Marketing News | pharmaphorum

News

FDA blocks Astellas’ Claudin cancer drug over manufacturing

Manufacturing problems have scuppered Astellas’ chances of approval in the US this month for zolbetuximab, currently leading the field among Claudin 18.2-targeted drug can

News

China is third country to approve Alzheimer’s drug Leqembi

Eisai and Biogen have a third regulatory approval for their amyloid-targeting Alzheimer’s disease therapy Leqembi, after it was greenlit by China’s National Medical Produc

News

Florida is first US state cleared to import Canadian drugs

The FDA has approved the first request from a US state to import prescription medicines from Canada, giving the green light to Florida for a programme that aims to reduce

News

Lilly launches telehealth option for obesity and other drugs

Eli Lilly has launched a new website-based access programme for some drugs like its new obesity therapy Zepbound, opening up a new direct-to-consumer (DTC) channel that could shake up

News

AbbVie hit as CVS says it will cut Humira from formularies

CVS Health has said it will remove AbbVie’s big-selling immunology drug Humira from most of its national formulary lists of reimbursable products, and offer biosimilar ver

News

Verona cuts $400m loan deal as it preps COPD drug for market

Verona Pharma has agreed a new $400 million debt facility with Oxford Finance and Hercules Capital designed to help the company navigate the possible approval and launch o

FDA blocks Astellas’ Claudin cancer drug over manufacturing

China is third country to approve Alzheimer’s drug Leqembi

Florida is first US state cleared to import Canadian drugs

Lilly launches telehealth option for obesity and other drugs

AbbVie hit as CVS says it will cut Humira from formularies

Verona cuts $400m loan deal as it preps COPD drug for market

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks